Demand for Postbiotic Supplements in EU is poised to grow from USD 4.00 Million in 2025 to USD 14.3 Million by 2036, at a steady CAGR of 12.3%. Capsules & Tablets will secure a 46.0% product form share, while Drug Stores is anticipated to lead in the distribution channel segment.